Niacinamide

Niacinamide

SCHEMBL6669309

CN1C(=O)C(Cc2ccc(F)c(F)c2)C(=O)c2cc(C(=O)O)ccc21.NC(=O)c1cccnc1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 1/20 0.41
PSEN2 P49810 1/20 0.41
APH1B Q8WW43 1/20 0.41
NCSTN Q92542 1/20 0.41
APH1A Q96BI3 1/20 0.41
PSENEN Q9NZ42 1/20 0.41
F7 P08709 1/20 0.37
F3 P13726 1/20 0.37
SARM1 Q6SZW1 1/20 0.37
SIRT2 Q8IXJ6 1/20 0.37
SIRT6 Q8N6T7 1/20 0.37
SIRT1 Q96EB6 1/20 0.37
SIRT3 Q9NTG7 1/20 0.37
SIRT5 Q9NXA8 1/20 0.37
SIRT4 Q9Y6E7 1/20 0.37
PRKAG1 P54619 1/20 0.35
PRKAA2 P54646 1/20 0.35
PRKAB1 Q9Y478 1/20 0.35
FYN P06241 1/20 0.34
CYP1A1 P04798 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6664689 0.90 PSEN1 (0.43) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6680077 0.87 NR1H2 (0.40) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6669268 0.82 ROCK2 (0.38) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6664479 0.82 ROCK2 (0.40) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6662371 0.80 MAOB (0.38) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6663962 0.79 ROCK2 (0.46) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6665597 0.79 ROCK2 (0.41) NR1H2NR1H3ALDH1A1ROCK2
SCHEMBL6681227 0.78 PRKAG1 (0.39) PRKAG1PRKAA2PRKAB1NR1H2NR1H3
SCHEMBL6685279 0.78 NR1H2 (0.38) NR1H2NR1H3ALDH1A1ROCK2
SCHEMBL6663534 0.76 NNMT (0.41) MKNK1MKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004014388-A1 6,6-FUSED HETEROARYL DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2004-02-19 WO disclosed